The Use of Glofitamab in Relapsed Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Falchi, Lorenzo [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, New York, NY 10065 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2024年 / 22卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 15
页数：4
相关论文
共 50 条
  • [1] Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Dickinson, Michael J.
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Corradini, Paolo
    Iacoboni, Gloria
    Khan, Cyrus
    Wrobel, Tomasz
    Offner, Fritz
    Wu, Shang-Ju
    Cartron, Guillaume
    Hertzberg, Mark
    Sureda, Anna
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    Dixon, Mark
    Clark, Emma
    Humphrey, Kathryn
    Hutchings, Martin
    Trney, Marek
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2220 - 2231
  • [2] Glofitamab in Relapsed Refractory Diffuse Large B-Cell Lymphoma: Single Center Experience
    Yaman, Samet
    Candir, Burcu Aslan
    Bozan, Ersin
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S445 - S445
  • [3] Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
    Atesoglu, Elif Birtas
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Fergun
    Koyun, Derya
    Alkis, Nihan
    Alacacioglu, Inci
    Sonmez, Mehmet
    Yavasoglu, Irfan
    Tombak, Anil
    Mehtap, Ozgur
    Kurnaz, Fatih
    Yuce, Orhan Kemal
    Karakus, Volkan
    Turgut, Mehmet
    Kurekci, Derya Deniz
    Ayer, Mesut
    Keklik, Muzaffer
    Buyuktas, Deram
    Ozbalak, Murat
    Ferhanoglu, Burhan
    [J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 663 - 673
  • [4] Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma
    Meyer, Kellie
    Huang, Danmeng
    O'Day, Ken
    Lahue, Betsy J.
    Wang, Anthony
    Mutebi, Alex
    Brodkin, Samantha
    Jun, Monika P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data
    Ferhanoglu, Burhan
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Asu Fergun
    Koyun, Derya
    Alkis, Nihan
    Atesoglu, Elif Birtas
    [J]. BLOOD, 2022, 140 : 6704 - 6705
  • [6] Management of Relapsed Diffuse Large B-Cell Lymphoma
    Kenkre, Vaishalee Padgaonkar
    Smith, Sonali M.
    [J]. CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 393 - 403
  • [7] Management of Relapsed Diffuse Large B-cell Lymphoma
    Crump, Michael
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (06) : 1195 - +
  • [8] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    [J]. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [9] Management of relapsed diffuse large B-cell lymphoma
    Vaishalee Padgaonkar Kenkre
    Sonali M. Smith
    [J]. Current Oncology Reports, 2008, 10 : 393 - 403
  • [10] Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma
    Davis, James A.
    Granger, Katelynn
    Sakowski, Alex
    Goodwin, Sara
    Herbst, Amanda
    Smith, Deidra
    Hendrickson, Lindsey
    Nachar, Victoria R.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (12) : 915 - 918
12345